Introduction
Jalra-M 50mg/850mg Tablet is a prescription medication used for the management of Type 2 diabetes mellitus. It contains a combination of two active ingredients: Metformin (850mg) and Vildagliptin (50mg). This medicine is manufactured by USV Ltd and comes in the form of 15 tablets in 1 strip with an MRP of ₹416.34.
Uses
Jalra-M 50mg/850mg Tablet is primarily used for the treatment of Type 2 diabetes mellitus. It helps to control blood sugar levels and improve insulin sensitivity in diabetic patients.
Price
The price of Jalra-M 50mg/850mg Tablet is ₹416.34 for a pack of 15 tablets.
Dosage
It is important to take Jalra-M 50mg/850mg Tablet exactly as prescribed by the doctor. The usual dosage is one tablet to be taken with food, once or twice daily. Do not chew, crush, or break the tablet, but swallow it whole.
Benefits
The benefits of Jalra-M 50mg/850mg Tablet include effective management of blood sugar levels, improvement in insulin sensitivity, and reduced risk of complications associated with Type 2 diabetes mellitus.
Side Effects
Some common side effects of Jalra-M 50mg/850mg Tablet may include:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Loss of appetite
- Dizziness
- Headache
- Trembling
- Metallic taste
- Hypoglycemia (low blood glucose level)
Active Ingredients
Jalra-M 50mg/850mg Tablet contains two active ingredients:
- Metformin (850mg)
- Vildagliptin (50mg)
Pharmacological Properties
The pharmacological properties of Jalra-M 50mg/850mg Tablet involve the combined actions of Metformin and Vildagliptin to regulate blood sugar levels and enhance insulin sensitivity in diabetic patients.
Indications
Jalra-M 50mg/850mg Tablet is indicated for the treatment of Type 2 diabetes mellitus in adults.
Contraindications
Jalra-M 50mg/850mg Tablet is contraindicated in individuals with a known hypersensitivity to Metformin, Vildagliptin, or any other ingredients of the tablet. It should not be used in patients with severe kidney or liver disease.
Drug Interactions
It is important to consult a healthcare provider before taking Jalra-M 50mg/850mg Tablet with other medications, as potential drug interactions may occur. Some drugs that may interact with this medicine include certain antibiotics, antifungals, and diuretics.
Patient Counseling
Patients should be advised to follow the prescribed dosage and schedule for Jalra-M 50mg/850mg Tablet. It is important to monitor blood sugar levels regularly and report any abnormal symptoms to the healthcare provider. Lifestyle modifications such as a healthy diet and regular exercise are also important in the management of diabetes.
Clinical Evidence
Clinical studies have demonstrated the efficacy of Jalra-M 50mg/850mg Tablet in controlling blood sugar levels and improving insulin sensitivity in patients with Type 2 diabetes mellitus. Consult a healthcare professional for more information on the specific clinical evidence supporting the use of this medication.
Frequently Asked Questions (FAQ)
Q: Can Jalra-M 50mg/850mg Tablet be taken without food?
A: It is recommended to take Jalra-M 50mg/850mg Tablet with food to minimize the risk of gastrointestinal side effects.
Q: Is Jalra-M 50mg/850mg Tablet habit-forming?
A: No, Jalra-M 50mg/850mg Tablet is not habit-forming.
Q: What should I do if I miss a dose of Jalra-M 50mg/850mg Tablet?
A: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
Q: How long does it take for Jalra-M 50mg/850mg Tablet to show its effects?
A: The onset of action of Jalra-M 50mg/850mg Tablet may vary from person to person. Consult your doctor for information specific to your condition.
Q: Are there any precautions to be taken while using Jalra-M 50mg/850mg Tablet?
A: Patients should avoid alcohol consumption while taking Jalra-M 50mg/850mg Tablet, as it may interfere with the medication’s effectiveness. It is also important to inform the healthcare provider about any other medications being taken to prevent potential drug interactions.
Q: Can Jalra-M 50mg/850mg Tablet be used in children?
A: Jalra-M 50mg/850mg Tablet is not recommended for use in children. Consult a pediatrician for suitable treatment options for pediatric patients with diabetes mellitus.
Q: What should I do in case of an overdose of Jalra-M 50mg/850mg Tablet?
A: In case of an overdose, seek immediate medical attention or contact a poison control center for assistance.
Q: Can Jalra-M 50mg/850mg Tablet cause hypoglycemia (low blood sugar)?
A: Yes, hypoglycemia is a potential side effect of Jalra-M 50mg/850mg Tablet. Patients should be cautious and monitor their blood sugar levels regularly while taking this medication.
Q: How long should I continue to take Jalra-M 50mg/850mg Tablet?
A: The duration of treatment with Jalra-M 50mg/850mg Tablet should be determined by the doctor based on the individual’s condition and response to the medication. Do not discontinue the medication without consulting a healthcare provider.
Q: Are there any dietary restrictions while taking Jalra-M 50mg/850mg Tablet?
A: Patients should follow a healthy diet recommended by the healthcare provider while taking Jalra-M 50mg/850mg Tablet to optimize the management of diabetes.
This enhanced content provides a comprehensive overview of Jalra-M 50mg/850mg Tablet, including its uses, dosage, benefits, side effects, active ingredients, pharmacological properties, indications, contraindications, drug interactions, patient counseling, and clinical evidence, along with detailed answers to frequently asked questions.
MRP:
₹416.34
Manufacturer:
USV Ltd
Salt:
Metformin (850mg) + Vildagliptin (50mg),
How to UseJalra-M 50mg/850mg Tablet:
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jalra-M 50mg/850mg Tablet is to be taken with food.
Side Effects of Jalra-M 50mg/850mg Tablet:
Nausea,Vomiting,Diarrhea,Stomach pain,Loss of appetite,Dizziness,Headache,Trembling,Metallic taste,Hypoglycemia (low blood glucose level),
Alternate Medicines for Jalra-M 50mg/850mg Tablet:
Vilact M 850 Tablet,Torglip M 50/850 Tablet,Encelin M 50/850 Tablet,Vildaprime M 850mg/50mg Tablet,Vildamac M 50/850 Tablet,
Prescription Required Status:
Prescription Required
Type of Selection:
15 tablets in 1 strip
Chemical Class:
Not Listed
Habit Forming:
No
Therapeutic Class:
ANTI DIABETIC
Action Class:
Not Listed
. Please note, this information is for educational purposes only and not intended as medical advice.
